Zelboraf receives FDA approval for treatment of metastatic melanoma

The U.S. Food and Administration today approved Zelboraf (vemurafenib), a to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin .


Read more

Related posts

Leave a Reply